Concepedia

Author

Kelly Lau

BioMarin (United States)ORCID

Also Known As

K Lau, K. H. T. LAU, Kelly Lau

19

Publications

386

Citations

9

H-Index

24

Concepts

All Affiliations

BioMarin (United States)University of Colorado DenverWashington University in St. LouisLurie Children's HospitalCornell University
KL

About

Kelly Lau is an author at BioMarin (United States) specializing in medicine, pathogenesis, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

103

2

Allergy

2

2

66

3

Immunology

2

2

66

4

Health Sciences

1

1

37

5

Clinical Nutrition

1

1

37

Kelly Lau

×

9

Publications

362

Citations

9

H-Index

YearCitations

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A

Brian Long, P. Véron, Klaudia Kuranda,

Molecular Therapy

2020

71

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

Soumi Gupta, Kelly Lau, Cary O. Harding,

EBioMedicine

2018

69

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial

Becky Schweighardt, Troy Tompkins, Kelly Lau,

Clinical Therapeutics

2014

55

Diagnostic clues to megaloblastic anaemia without macrocytosis

Clement Wn Chan, S. Y. H. LIU, Chi Shan Kho,

International Journal of Laboratory Hematology

2007

37

Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study

Nicola Longo, Roberto T. Zori, Melissa Wasserstein,

Orphanet Journal of Rare Diseases

2018

31

Monitoring cell-mediated immune responses in AAV gene therapy clinical trials using a validated IFN-γ ELISpot method

Kathryn Patton, Mike T. Harrison, Brian Long,

Molecular Therapy — Methods & Clinical Development

2021

31

Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up

Barbara K. Burton, Nicola Longo, Jerry Vockley,

Molecular Genetics and Metabolism

2020

30

Biomarker analysis of Morquio syndrome: identification of disease state and drug responsive markers

Lisa Argento Martell, Kelly Lau, Miranda Mei,

Orphanet Journal of Rare Diseases

2011

27

Depletion of interfering IgG and IgM is critical to determine the role of IgE in pegvaliase-associated hypersensitivity

Kevin Larimore, Thom Nguyen, Benjamin Badillo,

Journal of Immunological Methods

2019

11

Page 1